{"id":136347,"date":"2019-01-24T02:46:06","date_gmt":"2019-01-24T02:46:06","guid":{"rendered":"http:\/\/www.georgianewsdesk.com\/news\/story\/136347\/allergic-conjunctivitis-market-patients-treated-patients-by-countries-india-china-japan-us-uk-etc-disease-type-sac-pac-vkc-akc-gpc-drugs-profile-companies.html"},"modified":"2019-01-24T02:46:06","modified_gmt":"2019-01-24T02:46:06","slug":"allergic-conjunctivitis-market-patients-treated-patients-by-countries-india-china-japan-us-uk-etc-disease-type-sac-pac-vkc-akc-gpc-drugs-profile-companies","status":"publish","type":"post","link":"http:\/\/www.honolulunewsnow.com\/news\/story\/136347\/allergic-conjunctivitis-market-patients-treated-patients-by-countries-india-china-japan-us-uk-etc-disease-type-sac-pac-vkc-akc-gpc-drugs-profile-companies.html","title":{"rendered":"Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type (SAC, PAC, VKC, AKC, GPC), Drugs Profile &amp; Companies"},"content":{"rendered":"<div style=\"float:right;width:250px;padding:8px 10px 10px 10px\"><a rel=\"nofollow\" href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/01\/1548233872.jpeg\" style=\"border:none !important\" target=\"_blank\"><img loading=\"lazy\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/01\/1548233872.jpeg\" alt=\"\" width=\"225\" height=\"220\" style=\"padding:0px 0px 10px 10px;border:0 solid !important\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Allergic Conjunctivitis Market is expected to be more than USD 2 Billion market by 2025.<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic;padding:8px 0px\">Renub Research report titled \u201cGlobal Allergic Conjunctivitis Market, Patients, Treated Patients By Countries (India, China, Japan, US, UK, France, Germany, Italy, Spain), Disease Type (SAC, PAC,  VKC, AKC  &amp; GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) &amp; Companies, Growth Drivers, Challenges\u201d provides a complete analysis of global allergic conjunctivitis market.<\/div>\n<p style=\"text-align: justify\">Allergic conjunctivitis is a kind of eye disease in which it affect the eye surfaces and are commonly associated to immune-mediated inflammatory reactions of these structures. The prevalence of the allergic conjunctivitis is found more in summer and spring across the various regions. Pollen, dust, irritants such as cigarette smoke, perfumes etc. are some of the substance that triggers the conjunctivitis. Itching is the most typical sign of allergic conjunctivitis, and more than <strong>75 percent<\/strong> of patients report this symptom when seeking treatment. According to Renub Research <a rel=\"nofollow\" href=\"https:\/\/www.renub.com\/allergic-conjunctivitis-market-p.php\" target=\"_blank\">Allergic Conjunctivitis Market<\/a> is expected to be more than <strong>USD 2 Billion<\/strong> market by <strong>2025<\/strong>.<\/p>\n<p style=\"text-align: justify\">Global allergic conjunctivitis market will grow due to increasing prevalence of various allergic conjunctivitis, development in medical infrastructure in the developing countries, growing awareness about allergic conjunctivitis among people, increasing ageing population and upcoming therapies such as Zerviate, ADX-102, PRT-2761, OTX-DP etc. Allergic conjunctivitis are classified mainly in five types: Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) and Giant Papillary Conjunctivitis (GPC).<\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\">Request a <strong>free sample copy<\/strong> of the report:<\/p>\n<p style=\"text-align: justify\"><a rel=\"nofollow\" href=\"https:\/\/www.renub.com\/contactus.php\" target=\"_blank\">https:\/\/www.renub.com\/contactus.php<\/a><\/p>\n<p style=\"text-align: justify\"><strong>Renub Research<\/strong> report titled <strong>&ldquo;Global Allergic Conjunctivitis Market, Patients, Treated Patients By Countries (India, China, Japan, United States, United Kingdom, France, Germany, Italy, Spain), Disease Type (Seasonal Allergic Conjunctivitis (SAC) &amp; Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) And Giant Papillary Conjunctivitis (GPC)), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) Companies (Santen Pharmaceutical, Alcon (Novartis), Portola Pharmaceuticals, Ocular Therapeutix), Growth Drivers, Challenges&rdquo;<\/strong> provides a complete analysis of global allergic conjunctivitis market.<\/p>\n<p style=\"text-align: justify\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>China Dominates the Global Allergic Conjunctivitis Patient Population<\/strong><\/p>\n<p style=\"text-align: justify\">In this report, we have shown complete insight of country analysis of allergic conjunctivitis patient population. The covered countries are; India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. China dominates the global allergic conjunctivitis patient population numbers.<\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<img src=\"http:\/\/www.abnewswire.com\/uploads\/72d612ec9d97c3e8f70fb983fe366834.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify\"><strong>United States is the leading Country in the Global Allergic Conjunctivitis Market<\/strong><\/p>\n<p style=\"text-align: justify\">Allergic conjunctivitis market is growing across all parts of the world. Market growth rates varies in the countries covered in the report India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. United States is leading country in the global allergic conjunctivitis market due to growing awareness, strong healthcare support system and large patient population.<\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>Access full Research:&nbsp;<\/strong>&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.renub.com\/allergic-conjunctivitis-market-p.php\" target=\"_blank\">https:\/\/www.renub.com\/allergic-conjunctivitis-market-p.php<\/a><\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>Seasonal Allergic Conjunctivitis (SAC) &amp; Perennial Allergic Conjunctivitis (PAC) Hold Majority of Market in the Global Allergic Conjunctivitis Market<\/strong><\/p>\n<p style=\"text-align: justify\">On the basis of disease type, global Allergic conjunctivitis market is further segmented into seasonal allergic conjunctivitis (SAC) &amp; perennial allergic conjunctivitis (PAC) market, vernal keratoconjunctivitis (VKC) market, atopic keratoconjunctivitis (AKC) market and giant papillary conjunctivitis (GPC) market, globally. Seasonal allergic conjunctivitis (SAC) &amp; perennial allergic conjunctivitis (PAC) hold majority of market share in the global allergic conjunctivitis market.<\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>Allergic Conjunctivitis Pipe Line Drugs are Key Strength for this Market Place<\/strong><\/p>\n<p style=\"text-align: justify\">In the global allergic conjunctivitis market, allergic conjunctivitis pipe line drugs will play the major role for the growth of this market. At present several drugs such as Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.<\/p>\n<p style=\"text-align: justify\"><strong>Report has been analyzed from 9 Major Viewpoints<\/strong><\/p>\n<p style=\"text-align: justify\">1. Global Allergic Conjunctivitis Market <br \/>2. Global Allergic Conjunctivitis Market Share, Disease Type Market Share, Patients Share, Treated Patients Share <br \/>3. Country Allergic Conjunctivitis Market <br \/>4. Country Allergic Conjunctivitis Patients Population <br \/>5. Country Allergic Conjunctivitis Treated Patients Population <br \/>6. Disease Type Allergic Conjunctivitis Market <br \/>7. Allergic Conjunctivitis Drugs Pipeline<br \/>8. Growth Drivers and Challenges<br \/>9. Key Allergic Conjunctivitis Companies Initiatives and Financial Insight<\/p>\n<p style=\"text-align: justify\"><strong>Country Covered &ndash; Global Allergic Conjunctivitis Market<\/strong><\/p>\n<p style=\"text-align: justify\">&bull; India<br \/>&bull; China<br \/>&bull; Japan<br \/>&bull; United States<br \/>&bull; United Kingdom<br \/>&bull; France<br \/>&bull; Germany<br \/>&bull; Italy<br \/>&bull; Spain<\/p>\n<p style=\"text-align: justify\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<img src=\"http:\/\/www.abnewswire.com\/uploads\/7e130594aa277a85d9e3d35bab01d401.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>Disease Type Covered &ndash; Global Allergic Conjunctivitis Market<\/strong><\/p>\n<p style=\"text-align: justify\">&bull; Seasonal Allergic Conjunctivitis (SAC) &amp; Perennial Allergic Conjunctivitis (PAC)<br \/>&bull; Vernal Keratoconjunctivitis (VKC)<br \/>&bull; Atopic Keratoconjunctivitis (AKC)<br \/>&bull; Giant Papillary Conjunctivitis (GPC)<\/p>\n<p style=\"text-align: justify\"><strong>Drugs Profile Covered &ndash; Global Allergic Conjunctivitis Market<\/strong><\/p>\n<p style=\"text-align: justify\">&bull; Zerviate<br \/>&bull; OTX-DP<br \/>&bull; ADX-102<br \/>&bull; PRT-2761<br \/>&bull; CVXL-0074<br \/>&bull; AK-002<br \/>&bull; Bertilimumab<br \/>&bull; Reproxalap<br \/>&bull; ST-266<br \/>&bull; SYL-116011<\/p>\n<p style=\"text-align: justify\"><strong>Company Covered<\/strong><\/p>\n<p style=\"text-align: justify\">&bull; Santen Pharmaceutical<br \/>&bull; Alcon (Novartis)<br \/>&bull; Portola Pharmaceuticals<br \/>&bull; Ocular Therapeutix<\/p>\n<p style=\"text-align: justify\">If the information you seek is not included in the current scope of the study kindly share your specific requirements with our <strong>custom research team<\/strong> at <strong>info@renub.com<\/strong><\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>Browse Related Report :<\/strong><\/p>\n<p style=\"text-align: justify\"><a rel=\"nofollow\" href=\"https:\/\/www.renub.com\/epilepsy-drugs-market-p.php\" target=\"_blank\">Epilepsy Drugs Market<\/a><\/p>\n<p style=\"text-align: justify\"><a rel=\"nofollow\" href=\"https:\/\/www.renub.com\/spinal-muscular-atrophy-market-p.php\" target=\"_blank\">Spinal Muscular Atrophy Market<\/a><\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>Contact Us<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>Renub Research<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>Phone:<\/strong>+1-678-302-0700<\/p>\n<p style=\"text-align: justify\"><strong>Email:<\/strong> info@renub.com<\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>Key Topics Covered :<\/strong>&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>1. Executive Summary<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>2. Global Allergic Conjunctivitis Market and Patients Analysis<\/strong><\/p>\n<p style=\"text-align: justify\">2.1 Allergic Conjunctivitis Market<br \/>2.2 Allergic Conjunctivitis Patient Numbers<br \/>2.3 Allergic Conjunctivitis Treated Patient Numbers<\/p>\n<p style=\"text-align: justify\"><strong>3. Share Analysis &ndash; Global Allergic Conjunctivitis<\/strong><\/p>\n<p style=\"text-align: justify\">3.1 Country Market Share<br \/>3.2 Patients Population Share<br \/>3.3 Treated Patients Population Share<br \/>3.4 By Disease Type Share<\/p>\n<p style=\"text-align: justify\"><strong>4. India<\/strong><\/p>\n<p style=\"text-align: justify\">4.1 Allergic Conjunctivitis Patient Numbers<br \/>4.2 Allergic Conjunctivitis Treated Patient Numbers<br \/>4.3 Allergic Conjunctivitis Market<\/p>\n<p style=\"text-align: justify\"><strong>5. China<\/strong><\/p>\n<p style=\"text-align: justify\">5.1 Allergic Conjunctivitis Patient Numbers<br \/>5.2 Allergic Conjunctivitis Treated Patient Numbers<br \/>5.3 Allergic Conjunctivitis Market<\/p>\n<p style=\"text-align: justify\"><strong>6. Japan<\/strong><\/p>\n<p style=\"text-align: justify\">6.1 Allergic Conjunctivitis Patient Numbers<br \/>6.2 Allergic Conjunctivitis Treated Patient Numbers<br \/>6.3 Allergic Conjunctivitis Market<\/p>\n<p style=\"text-align: justify\"><strong>7. United States<\/strong><\/p>\n<p style=\"text-align: justify\">7.1 Allergic Conjunctivitis Patient Numbers<br \/>7.2 Allergic Conjunctivitis Treated Patient Numbers<br \/>7.3 Allergic Conjunctivitis Market<\/p>\n<p style=\"text-align: justify\"><strong>8. United Kingdom<\/strong><\/p>\n<p style=\"text-align: justify\">8.1 Allergic Conjunctivitis Patient Numbers<br \/>8.2 Allergic Conjunctivitis Treated Patient Numbers<br \/>8.3 Allergic Conjunctivitis Market<\/p>\n<p style=\"text-align: justify\"><strong>9. France<\/strong><\/p>\n<p style=\"text-align: justify\">9.1 Allergic Conjunctivitis Patient Numbers<br \/>9.2 Allergic Conjunctivitis Treated Patient Numbers<br \/>9.3 Allergic Conjunctivitis Market<\/p>\n<p style=\"text-align: justify\"><strong>10. Germany<\/strong><\/p>\n<p style=\"text-align: justify\">10.1 Allergic Conjunctivitis Patient Numbers<br \/>10.2 Allergic Conjunctivitis Treated Patient Numbers<br \/>10.3 Allergic Conjunctivitis Market<\/p>\n<p style=\"text-align: justify\"><strong>11. Italy<\/strong><\/p>\n<p style=\"text-align: justify\">11.1 Allergic Conjunctivitis Patient Numbers<br \/>11.2 Allergic Conjunctivitis Treated Patient Numbers<br \/>11.3 Allergic Conjunctivitis Market<\/p>\n<p style=\"text-align: justify\"><strong>12. Spain<\/strong><\/p>\n<p style=\"text-align: justify\">12.1 Allergic Conjunctivitis Patient Numbers<br \/>12.2 Allergic Conjunctivitis Treated Patient Numbers<br \/>12.3 Allergic Conjunctivitis Market<\/p>\n<p style=\"text-align: justify\"><strong>13. Disease Type &ndash; Global Allergic Conjunctivitis Market<\/strong><\/p>\n<p style=\"text-align: justify\">13.1 Seasonal Allergic Conjunctivitis (SAC) &amp; Perennial Allergic Conjunctivitis (PAC)<br \/>13.2 Vernal Keratoconjunctivitis (VKC)<br \/>13.3 Atopic Keratoconjunctivitis (AKC)<br \/>13.4 Giant Papillary Conjunctivitis (GPC)<\/p>\n<p style=\"text-align: justify\"><strong>14. Global Allergic Conjunctivitis Drugs Profile\/Pipe Line Drugs<\/strong><\/p>\n<p style=\"text-align: justify\">14.1 Zerviate<br \/>14.2 OTX-DP (Dexamethasone Insert)<br \/>14.3 ADX-102<br \/>14.4 PRT2761<br \/>14.5 CVXL-0074<br \/>14.6 AK-002<br \/>14.7 Bertilimumab<br \/>14.8 Reproxalap<br \/>14.9 ST-266<br \/>14.10 SYL-116011<\/p>\n<p style=\"text-align: justify\"><strong>15. Growth Driver<\/strong><\/p>\n<p style=\"text-align: justify\">15.1 Rapid Urbanization and Growth of Particulate Pollution<br \/>15.2 Increasing Ageing Population &amp; Widespread Use of Medications for Various Eye Diseases<\/p>\n<p style=\"text-align: justify\"><strong>16. Challenges<\/strong><\/p>\n<p style=\"text-align: justify\">16.1 Diagnostic Challenges<br \/>16.2 Undertreated by Patients<\/p>\n<p style=\"text-align: justify\"><strong>17. Santen Pharmaceutical<\/strong><\/p>\n<p style=\"text-align: justify\">17.1 Company Overview<br \/>17.2 Initiatives<br \/>17.3 Financial Insight<\/p>\n<p style=\"text-align: justify\"><strong>18. Alcon Inc. (Novartis)<\/strong><\/p>\n<p style=\"text-align: justify\">18.1 Company Overview<br \/>18.2 Initiatives<br \/>18.3 Financial Insight<\/p>\n<p style=\"text-align: justify\"><strong>19. Portola Pharmaceuticals Inc.<\/strong><\/p>\n<p style=\"text-align: justify\">19.1 Company Overview<br \/>19.2 Initiatives<br \/>19.3 Financial Insight<\/p>\n<p style=\"text-align: justify\"><strong>20. Ocular Therapeutix Inc.<\/strong><\/p>\n<p style=\"text-align: justify\">20.1 Company Overview<br \/>20.2 Initiatives<br \/>20.3 Financial Insight<\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>About Us<\/strong><\/p>\n<p style=\"text-align: justify\">Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.<\/p>\n<p class=\"caps\"><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a rel=\"nofollow\" href=\"http:\/\/www.abnewswire.com\/companyname\/renub.com\/life-science-1-c.php_23240.html\">Renub Research<\/a><br \/><strong>Contact Person:<\/strong> Rajat Gupta<br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"http:\/\/www.abnewswire.com\/email_contact_us.php?pr=allergic-conjunctivitis-market-patients-treated-patients-by-countries-india-china-japan-us-uk-etc-disease-type-sac-pac-vkc-akc-gpc-drugs-profile-companies\">Send Email<\/a><br \/><strong>Phone:<\/strong> 6783020700<br \/><strong>Address:<\/strong>225 Kristie Ln  <br \/><strong>City:<\/strong> Roswell<br \/><strong>State:<\/strong> GA<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a rel=\"nofollow\" href=\"http:\/\/www.renub.com\/life-science-1-c.php\" target=\"_blank\">www.renub.com\/life-science-1-c.php<\/a><\/p>\n<p><img loading=\"lazy\" src=\"http:\/\/www.abnewswire.com\/press_stat.php?pr=allergic-conjunctivitis-market-patients-treated-patients-by-countries-india-china-japan-us-uk-etc-disease-type-sac-pac-vkc-akc-gpc-drugs-profile-companies\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Allergic Conjunctivitis Market is expected to be more than USD 2 Billion market by 2025. Renub Research report titled \u201cGlobal Allergic Conjunctivitis Market, Patients, Treated Patients By Countries (India, China,<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/posts\/136347"}],"collection":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/comments?post=136347"}],"version-history":[{"count":0,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/posts\/136347\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/media?parent=136347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/categories?post=136347"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/tags?post=136347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}